Andreas Harstrick

Chief Tech/Sci/R&D Officer at AFFIMED N.V.

65 year

Health Technology

Consumer Services

Commercial Services

Profile

Andreas Harstrick is currently the Chief Medical Officer at Affimed NV.
He previously worked as the Director at Lilly Oncology.
From 2008 to 2014, he served as the Senior Vice President-Medical Sciences at ImClone LLC.
He was also the Chief Medical Officer at Molecular Partners AG from 2015 to 2019.
Prior to that, he held the position of SVP-Global Clinical Development Unit Oncology at Merck Serono Ltd. from 1998 to 2008.
Dr. Harstrick's education includes a doctorate degree from the University of Hannover in 1986.

Andreas Harstrick active positions

Companies	Position	Start
AFFIMED N.V.	Chief Tech/Sci/R&D Officer	01/03/2020

All active positions of Andreas Harstrick

Former positions of Andreas Harstrick

Companies	Position	End
MOLECULAR PARTNERS AG	Chief Tech/Sci/R&D Officer	01/09/2019
ImClone LLC ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer	Corporate Officer/Principal	01/01/2014
Merck Serono Ltd. Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs	Corporate Officer/Principal	01/01/2008
University of Duisburg-Essen University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Lilly Oncology Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services	Director/Board Member	-

See the detail of Andreas Harstrick's experience

Training of Andreas Harstrick

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andreas Harstrick's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
ImClone LLC ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer	Health Technology
Affimed NV Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs	Health Technology
University of Hannover University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Duisburg-Essen University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Molecular Partners AG Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products	Health Technology
Merck Serono Ltd. Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs	Commercial Services
Lilly Oncology Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services	Health Services